By Forbes |
January 22, 2020
Just about every Medicare beneficiary has heard about the donut hole in a Medicare Part D drug plan. Many will admit they don’t understand it but they all know it means drugs will cost more.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.